Eminence Capital LP Invests $225.26 Million in Tenet Healthcare Corporation $THC

Eminence Capital LP acquired a new stake in shares of Tenet Healthcare Corporation (NYSE:THC) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 1,109,450 shares of the company’s stock, valued at approximately $225,263,000. Tenet Healthcare accounts for about 2.7% of Eminence Capital LP’s investment portfolio, making the stock its 11th biggest holding. Eminence Capital LP owned approximately 1.26% of Tenet Healthcare at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in the stock. WCM Investment Management LLC lifted its position in Tenet Healthcare by 244.4% in the 3rd quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock valued at $102,657,000 after purchasing an additional 362,083 shares during the last quarter. AlphaQuest LLC increased its stake in shares of Tenet Healthcare by 238.3% in the third quarter. AlphaQuest LLC now owns 5,965 shares of the company’s stock valued at $1,211,000 after purchasing an additional 4,202 shares during the period. Winnow Wealth LLC acquired a new position in shares of Tenet Healthcare during the third quarter worth approximately $1,129,000. Cerity Partners LLC grew its holdings in Tenet Healthcare by 10.4% in the 2nd quarter. Cerity Partners LLC now owns 120,623 shares of the company’s stock worth $21,230,000 after buying an additional 11,395 shares in the last quarter. Finally, Savant Capital LLC raised its stake in Tenet Healthcare by 27.5% during the 3rd quarter. Savant Capital LLC now owns 16,894 shares of the company’s stock valued at $3,430,000 after acquiring an additional 3,647 shares in the last quarter. 95.44% of the stock is currently owned by institutional investors.

Insider Activity

In other news, insider R. Scott Ramsey sold 8,017 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total value of $1,865,555.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Thomas W. Arnst sold 8,000 shares of the company’s stock in a transaction on Monday, March 9th. The shares were sold at an average price of $238.85, for a total value of $1,910,800.00. Following the transaction, the executive vice president directly owned 12 shares in the company, valued at $2,866.20. The trade was a 99.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 48,695 shares of company stock valued at $11,373,201 in the last 90 days. Company insiders own 0.81% of the company’s stock.

Tenet Healthcare Trading Up 1.4%

Shares of THC opened at $227.79 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18. Tenet Healthcare Corporation has a 1-year low of $109.82 and a 1-year high of $247.21. The stock has a market capitalization of $19.81 billion, a P/E ratio of 14.71, a P/E/G ratio of 1.12 and a beta of 1.39. The business’s 50-day moving average price is $213.46 and its 200 day moving average price is $204.15.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, topping the consensus estimate of $4.08 by $0.62. The company had revenue of $5.53 billion during the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The business’s revenue for the quarter was up 8.9% on a year-over-year basis. During the same period last year, the company posted $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Analysts expect that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. Royal Bank Of Canada increased their price target on Tenet Healthcare from $253.00 to $277.00 and gave the stock an “outperform” rating in a research note on Thursday, February 12th. Wells Fargo & Company reiterated an “overweight” rating and issued a $265.00 target price on shares of Tenet Healthcare in a research report on Monday, February 16th. KeyCorp upped their price target on shares of Tenet Healthcare from $225.00 to $250.00 and gave the stock an “overweight” rating in a research note on Thursday, February 12th. Truist Financial raised their price objective on shares of Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a research note on Tuesday, February 17th. Finally, Weiss Ratings raised Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $250.56.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.